Skip to main content
Launch offer40% off your first paymentEnds 31 DecemberSee plans
DELFI Diagnostics, Inc. logo

DELFI Diagnostics, Inc.

Biotech & Pharmaceuticals
WebsiteLinkedIn

DELFI Diagnostics develops AI-powered liquid biopsy tests using fragmentomics technology to help detect cancer early through simple blood draws. Founded in 2019, DELFI Diagnostics is a precision oncology company that combines machine learning with genome-wide analysis of cell-free DNA fragments to develop accessible, high-performance cancer screening and treatment monitoring tests.

Open roles
1
Company size
51 - 200 employees
Headquarters
1810 Embarcadero Road, Suite 100, Palo Alto, CA 94303
Founded
2019

Follow DELFI Diagnostics, Inc.

Create an exact-company alert for on-site matches and optional daily email.

Open roles